Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes
And I am really, really grateful for that
Our improved understanding of the complex biological regulation of appetite, metabolism and body weight, involving co-ordinated responses between peripheral tissues and central appetite-regulating centres, has resulted in the availability of nine Food and Drug Administration (FDA) (liraglutide, semaglutide, tirzepatide, orlistat, phentermine, phentermine/topiramate, bupropion-naltrexone, setmelanotide, and metreleptin), and seven European Medicine Agency (EMA) (excluding phentermine and phentermine/topiramate), approved AOMs
McGinnis JM, Fineberg HV, Dzau VJ (2021) Advancing the learning health system